Key terms
About ADAG
Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ADAG news
Apr 05
6:30am ET
Analysts Offer Insights on Healthcare Companies: eFFECTOR Therapeutics (EFTR), Adagene (ADAG) and Aquestive Therapeutics (AQST)
Mar 29
3:57pm ET
Adagene Inc. Strikes Deal to Sell Depositary Shares
Mar 29
9:57am ET
Adagene’s Breakthroughs Promise Future Growth
Feb 09
6:07am ET
Adagene announces progress in program for ADG126 and KEYTRUDA
Jan 22
12:10pm ET
Analysts Conflicted on These Healthcare Names: Abbott Labs (ABT), Adagene (ADAG) and Teleflex (TFX)
Jan 17
11:21am ET
Morgan Stanley ‘encouraged’ by 2 cPRs reported by Adagene
Jan 17
11:16am ET
Adagene falls after presenting interim results from study of ADG126
No recent press releases are available for ADAG
ADAG Financials
Key terms
Ad Feedback
ADAG Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ADAG Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
